Filing Flows › Comparisons › NMTC vs AURX
Neuroone Medical Technologies vs Nuo Therapeutics: NMTC and AURX compared
Neuroone Medical Technologies is the larger company: $2.0M of revenue in its latest quarter (Q3 FY26) against $1.8M for Nuo Therapeutics (Q2 2026). Nuo Therapeutics is growing faster (+153% against +16% a year earlier). Nuo Therapeutics is more profitable, with an operating margin of -9.4% against -122.9%.
Where the money goes: NMTC and AURX
Neuroone Medical Technologies (NMTC) · Q3 FY26
Neuroone Medical Technologies, Q3 FY26: revenue $2.0M (+16% year over year), operating margin -122.9%, net loss $2.0M, operating cash flow −$1.1M. The chart follows the revenue to costs, profit and cash.
Nuo Therapeutics (AURX) · Q2 2026
Nuo Therapeutics, Q2 2026: revenue $1.8M (+153% year over year), operating margin -9.4%, net loss $278K, operating cash flow −$236K. The chart follows the revenue to costs, profit and cash.
| Neuroone Medical Technologies (NMTC) | Nuo Therapeutics (AURX) | |
|---|---|---|
| Latest quarter | Q3 FY26 | Q2 2026 |
| Revenue | $2.0M | $1.8M |
| Revenue growth, Y/Y | +16% | +153% |
| Operating margin | -122.9% | -9.4% |
| Net earnings | −$2.0M | −$278K |
| Net margin | -101.7% | -15.7% |
| Operating cash flow | −$1.1M | −$236K |
Where the revenue comes from
Nuo Therapeutics
- Product: $1.7M (96%)
- Aurix and Private Label Centrifuge Devices: $72K (4%)
Questions
Which is bigger, Neuroone Medical Technologies or Nuo Therapeutics?
Neuroone Medical Technologies is the larger company: $2.0M of revenue in its latest quarter (Q3 FY26) against $1.8M for Nuo Therapeutics (Q2 2026).
Is Neuroone Medical Technologies or Nuo Therapeutics growing faster?
Nuo Therapeutics is growing faster (+153% against +16% a year earlier).
Which is more profitable, Neuroone Medical Technologies or Nuo Therapeutics?
Nuo Therapeutics is more profitable, with an operating margin of -9.4% against -122.9%.
More: Neuroone Medical Technologies earnings · how Neuroone Medical Technologies makes money · Nuo Therapeutics earnings · how Nuo Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.